CDKN2A and cancer: This study utilized an integrated multi-omics approach to examine CDKN2A dysregulation in cervical squamous cell carcinoma (CESC) and UCEC.<h4>Methods</h4>Pan-cancer and tumor-normal differential expression analyses were performed using TIMER2.0 and GEPIA2 (TCGA/GTEx).